The CCS recommends NT-proBNP or BNP testing before non-cardiac surgeries in patients who are 65 years or older, those between 45 and 64 years with significant cardiovascular disease, or those with an RCRI score ≥ 1 (Strong Recommendation; Moderate Quality Evidence) [13]. This evidence concerns the gene NPPB and cardiovascular disorder.